Hair loss is different from hair falling. While hair fall may be a temporary exhaustion of hair follicles, the later is a permanent inflammation of hair follicles, the main reason of which is androgenic alopecia, but there are other many, less common types. Androgenic alopecia is occurred due to the reaction of 5alpha reeducates, a steroidal reaction that occurs in the androgens which secretes a different type of hormone called Dihydrotestosterone (DHT) in the dermal papillae which inflames hair follicles gradually destroying them.
The treatment of androgenic alopecia with medication involves two major drugs, Finasteride and Minoxidil, among other formulas. Finasteride is controls the 5-a reductive and prevents the androgens from secreting too much DHT. The drug was originally marketed to treat prostate cancer and the 5-a reductase inhibition was a side effect, which is now utilized purposefully.
Minoxidil was discovered as a similar side effect for a drug that was originally an antihypertensive, sold as an oral pill for the treatment of high blood pressure. With the regular consumption fo the drug, patients noticed an elevation of hair growth, which is now utilized on purpose, though as a topical lotion and foam format.
What differs men and women is their biological systems and hormonal levels when it comes to hair loss treatment for androgenic alopecia, which occurs differently in men and women as well. While men face varying amount of baldness and hairline recession in the center and front of the scalp in a precise pattern, women face a highly diffusive hair loss either all over the scalp or in the center of front of the scalp.
For the varying levels of hormone it is more viable for women to use topical hair loss mediation than use oral drugs, which have off label uses such as treating high blood pressure or prostate cancer. So when the patient does not have these diseases there is no legitimacy to use these drugs for the benefit of their side effects.
Usually women are prescribed Minoxidil 2% for daily application. It is the only FDA approved formulation, and other formulation of 5% minoxidil is not FDA approved. The daily application of 2% can slow down androgenic inflammation often hair follicles but not stop the process.
There may be other hair loss types that occur with the same features of androngic hair thinning in the crown region, such as telogen effluvium, or alopecia areata. With the application of non-androgenic alopecia, the application of Minoxidil 2% is most likely to regain a feasible hair growth and prevent hair follicle inflammation.
Finasteride oral tablets are not usually prescribed for women, because it’s primary action in prostate diseases.